Free Trial
NYSE:AGL

Agilon Health (AGL) Stock Price, News & Analysis

Agilon Health logo
$1.20 -0.07 (-5.12%)
Closing price 09/3/2025 03:59 PM Eastern
Extended Trading
$1.20 -0.01 (-0.41%)
As of 09/3/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Agilon Health Stock (NYSE:AGL)

Key Stats

Today's Range
$1.19
$1.28
50-Day Range
$0.86
$2.40
52-Week Range
$0.71
$6.08
Volume
4.45 million shs
Average Volume
22.81 million shs
Market Capitalization
$499.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.07
Consensus Rating
Hold

Company Overview

Agilon Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

AGL MarketRank™: 

Agilon Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 552nd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on 4 buy ratings, 12 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Agilon Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Agilon Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Agilon Health are expected to grow in the coming year, from ($0.59) to ($0.40) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agilon Health is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agilon Health is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Agilon Health has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Agilon Health's valuation and earnings.
  • Percentage of Shares Shorted

    6.29% of the float of Agilon Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilon Health has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agilon Health has recently increased by 1.00%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Agilon Health does not currently pay a dividend.

  • Dividend Growth

    Agilon Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.29% of the float of Agilon Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilon Health has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agilon Health has recently increased by 1.00%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Agilon Health has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Agilon Health this week, compared to 5 articles on an average week.
  • Search Interest

    12 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Agilon Health to their MarketBeat watchlist in the last 30 days.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGL Stock News Headlines

Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

Agilon Health's stock was trading at $1.90 at the beginning of 2025. Since then, AGL stock has decreased by 36.6% and is now trading at $1.2050.

Agilon Health, Inc. (NYSE:AGL) released its quarterly earnings data on Monday, August, 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by $0.14. The company's revenue for the quarter was down 5.9% compared to the same quarter last year.
Read the conference call transcript
.

Agilon Health (AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Agilon Health's top institutional investors include Geode Capital Management LLC (1.73%), Bank of America Corp DE (0.92%), Amundi (0.43%) and Marshall Wace LLP (0.36%). Insiders that own company stock include Cd&R Investment Associates Ix,, Veeral Desai, John William Wulf, Benjamin Shaker, Karen Mcloughlin, Steven Sell, Diana Mckenzie, Benjamin Kornitzer, Jeffrey A Schwaneke and Timothy Gertsch.
View institutional ownership trends
.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/04/2025
Today
9/04/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:AGL
CIK
1831097
Fax
N/A
Employees
650
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$1.00
Potential Upside/Downside
+154.9%
Consensus Rating
Hold
Rating Score (0-4)
2.11
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$260.15 million
Net Margins
-5.35%
Pretax Margin
-5.55%
Return on Equity
-66.76%
Return on Assets
-17.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$6.06 billion
Price / Sales
0.08
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.99 per share
Price / Book
1.22

Miscellaneous

Outstanding Shares
414,420,000
Free Float
399,628,000
Market Cap
$499.38 million
Optionable
Not Optionable
Beta
0.11
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:AGL) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners